Nanoprobes is a nanoparticle research collaborative, dedicated to finding cures for cancer and other diseases.
Our funding comes from research grants
and sales of nanoparticle products to the scientific community.
All profits support our research.
Research News
I am a heading
Here goes your text … Select any part of your text to access the formatting toolbar.
I am a heading
Here goes your text … Select any part of your text to access the formatting toolbar.
In memoriam
Dr. Wenqiu Liu, PhD
This work is dedicated to Dr. Wenqiu Liu, who died of triple negative breast cancer at the age of 57.
As Nanoprobes’ Production Manager for many years, Wenqiu was a key member of our team, and we miss her greatly. Her contributions live on in the many useful products she helped develop from our nanoparticles, still in wide use today across the research community.
The Nanoprobes Story
Nanoprobes was founded in 1990 by Dr. James F. Hainfeld, along with a group of scientists who were also alumni of Brookhaven National Laboratory. The independent research facility they formed has allowed Dr. Hainfeld and his colleagues the freedom to pursue some of the greatest challenges in research: seeking cures for cancer and other diseases.
Our research is performed by our highly skilled team of research chemists and biophysicists, in collaboration with leading researchers at universities and private laboratories. The company has received many grants from the NIH and NSF through the Small Business Innovation Research (SBIR) program, which support many of our research activities.
Nanoparticle products for the scientific community
While part of the funding for these endeavors has come from research grants, another source had to be found, as the scientific community faces ever-increasing government cutbacks. To this end, Nanoprobes began to offer many of the nanoparticle technologies developed by its members for use in other scientists’ research.
In our pursuit of cancer therapeutics, Nanoprobes has engineered some of the most sensitive reagents and technology for detecting biological molecules.
Our unique gold labeling technology uses chemically cross-linked metal clusters and nanoparticles as labels. This incredibly versatile platform has become an important part of biological detection and imaging across many fields of research. Our 1.4 nm Nanogold® probes alone have been cited in over 250 publications.
Our research: Nanoparticle therapeutics for cancer treatment
Our research has put our precision nanoparticles to work fighting cancer.
We have developed new technology to expand the uses of our nanoparticle labels for sensitive and rapid tumor diagnostics, imaging and even to greatly enhance radiotherapy.